Teams
IMATHERa highly specialised staff includes a multidisciplinary team led by Dr Bertrand Collin, radiopharmacist-teacher-researcher in charge of the team, Dr Alexandra Oudot, deputy team leader, Dr Pierre-Simon Bellaye, head of academic research, Dr Alexandre Dias, research engineer and Alex Helbling, study director. The team also includes a radiophysicist (Dr Jean-Marc Vrigneaud), two people with expertise in radiation protection (Lydie Houot and Mickael Pichon) and a PET/MRI imaging research engineer (Dr Alan Courteau). IMATHERa's work is supported by a highly specialised technical team (Marie Monterrat, Mélanie Guillemin and John Simonet) and students (Alexanne Bouchard, PhD student, Jame Frenay, PhD student, Romain Fontaine-Tuffery, PhD student and Camille Petitot, PhD student).
The complementary nature of this multidisciplinary team means that we can work towards a common goal: improving personalised patient care through imaging and radiotheranostics.
Group Leaders
Emeric Limagne
Group Leader
Emeric Limagne, Ph.D. is a Researcher in Tumor Immunology at the Centre Georges-François Leclerc (CGFL). He is also a member of the INSERM UMR 1231 research unit at the Université de Bourgogne.
Originally from France, Emeric Limagne completed his Master’s studies with a focus on cellular biology and immunology.
Then Emeric pursued his Ph.D. at the Université de Bourgogne. Mentored by Prof. François Ghiringhelli, Emeric’s thesis was on cancer immunology and the tumor microenvironment. In his subsequent post-doctoral and research work, Emeric has focused extensively on the interactions between cancer cells and the immune system at the CGFL.
His current research focus is on tumor immunology with a specific interest in the tumor microenvironment, immunogenic cell death, and the mechanisms of resistance to immunotherapies in cancer.
Researchers
Anthony Di Roio
Ph.D. Researcher
Anthony is a Ph.D. researcher in the tumor immunology team at the Centre Georges-François Leclerc (CGFL) and INSERM UMR 1231.
His current research focuses on targeting the tumor immune stroma and understanding the mechanisms of resistance to cancer therapies.
Previously, Anthony completed his research at the Cancer Research Center of Lyon (CRCL), where he investigated how MDR1-expressing CD4+ T cells resist chemotherapy and their role in anti-cancer immunity.
Students
Pauline Russo
3rd-year Ph.D. student
Pauline is a 3rd-year Ph.D. student at the Université de Bourgogne, conducting her research at the Centre Georges-François Leclerc (CGFL).
Her current research interests focus on optimizing the immunological and therapeutic effects of personalized vaccination by targeting oncogenic pathways in non-immunogenic tumors.
Previously, her research work has involved studying cancer cell-derived cytokines, such as IL-1β, and their role in reversing chemo-immunotherapy resistance in lung cancer.
Cyriane Poirier
1st-year Ph.D. student
Cyriane is a 1st-year Ph.D. student at the Université de Bourgogne, working in the INSERM UMR 1231 unit at the Centre Georges-François Leclerc (CGFL).
Her current research interests focus on the tumor microenvironment and identifying targeted therapy combinations to sensitize ‘cold’ tumors, such as triple-negative breast cancer, to immunotherapies.
Research Team
Lorenza Pillas
Research Team
Lorenza is a 1st-year student pursuing a degree at EPHE, conducting her research at the Centre Georges-François Leclerc (CGFL).
Her current research interests focus on tumor immunology and interactions within the cancer microenvironment.
Lisa Nuttin
Research Team
Lisa is a Research Technician at the Centre Georges-François Leclerc (CGFL) and INSERM UMR 1231. Her current work supports translational research on the tumor microenvironment, specifically focusing on the cross-talk between innate immune cells like macrophages or NK cells and T-cells in ‘cold’ tumors.
Charlène Latour
Research Team
Lab Alumni
Jeanne Aubin
Medical Intern
Loïck Galland
Oncologist
Laura Kalfeist
PhD in Immuno-oncology
Marjorie Bon
Samia Kada-Mohammed
Surgeon
Fumet Jean-David
Oncologist
Amandine Vallet
PhD in Cellular Oncology
